Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify "septic" intensive care unit patients. - Heagy,W.; Hansen,C.; Nieman,K.; Cohen,M.; Richardson,C.; Rodriguez,J.L.; West,M.A. (Shock, 2000)